Laurete Pharma carries out its activities and provides medical services within New Jersey. We are an active participant in the government program of import substitution in the framework of public procurement of medicines. The company has its own scientific and technical base, where a full technological cycle is organized: from fine chemical synthesis of pharmaceutical substances and interleukins to the creation of finished dosage forms.
The company's strategic efforts are aimed at developing and launching pulmonary drugs on the New Jersey market. The company cooperates with a wide range of well-known pharmaceutical companies in NJ such as Arius Pharmaceuticals, "pioneers" of complex technological solutions such as Contract Pharma and Safeguard Scientifics.
The company's strategic efforts are aimed at developing and launching pulmonary drugs on the New Jersey market. The company cooperates with a wide range of well-known pharmaceutical companies in NJ such as Arius Pharmaceuticals, "pioneers" of complex technological solutions such as Contract Pharma and Safeguard Scientifics.
Services
It is a busy time here as our company has reached a significant milestone, one which will serve to accelerate your timelines from development through production.
We have secured $20 million in capital, which will be used for strategically-planned improvements to our client offerings by creating a new testing unit, enhancing our scientific expertise, adding to our process development toolbox and enabling Laureate to expand cGMP production capacity.
We have secured $20 million in capital, which will be used for strategically-planned improvements to our client offerings by creating a new testing unit, enhancing our scientific expertise, adding to our process development toolbox and enabling Laureate to expand cGMP production capacity.
The future of the pharmaceutical industry is inseparably connected with the rapid development of biopharmaceutical technology. The basis of biotechnological production of drugs comprises of various biological processes. These drugs include various vaccines, preparations for allergen-specific and gene therapy, drugs and other useful pharmacological products.
Protein Expression: Our scientists use cell culture and molecular biology techniques to maximize cell line productivity and adapt cells to grow well in defined media compatible with downstream processing. Bioreactor Operations: Our well-trained specialists scale up culture of protein-producing cells from pilot through cGMP production scale.
Our Quality Systems consist of Quality Control (QC), Quality Assurance (QA), Microbiology and Validation. The integration of all these functional operations ensures compliance at every step of the cGMP and manufacturing process. The Quality System department works closely with manufacturing groups to assure adherence to quality standards in all systems and processes throughout Laureate Pharma's facilities.
The scientists at Laureate have the unique capability and track record in developing radiolabeled antibodies for cancer therapy. At Laureate, we have a team of specialists who can perform chemical conjugation of molecules with proteins for clinical and commercial scale and have special expertise in working with conjugation of chelators to proteins for radiolabelling.
Reviews
Be the first to review Laureate Pharma.
Write a Review
